Publication of Annual Report and Notice of AGM

Blog image

Alderley Park, 9 March 2022 - BiVictriX Therapeutics plc (AIM: BVX), an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience, today announces that its annual report and financial statements for the year ended 31 December 2021 ("Annual Report and Accounts") are available for download on the Company's website at  https://www.bivictrix.com/investor-centre; and confirms the date for its Annual General Meeting ("AGM").

 

The Annual Report and Accounts will be mailed to shareholders, who have elected to opt out on receiving electronic communications, later today.

 

The Company will hold its AGM on Thursday, 31 March 2022 at 12:00pm GMT at the Company’ registered office, Mereside Alderley Park, Alderley Edge, Manchester, SK10 4TG.

 

newsletter

Contact BivictriX

Please submit the form below and we shall be in touch
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
AntibodyPatient Image